
Organ transplantation is an essential healthcare treatment for patients with end-stage organ failure and severe chronic diseases. However, the global organ supply currently meets <10% of the global demand, resulting in extensive waiting lists. One of the primary reasons for discarding organs suitable for transplantation is their contamination by microorganisms. Methylene blue (MB) is a well-known photosensitizer that has shown promising results for microbiological control using photodynamic therapy. Nevertheless, antimicrobial photodynamic therapy (aPDT) for organ decontamination has produced an insufficient antimicrobial response in ex vivo graft experiments and in the presence of biological fluids. The present study investigated the aspects involved in the photodynamic response of MB into the organ preservation solutions STEEN and Custodiol HTK, based on its in vitro photodegradation kinetics and the resulting bacterial inactivation. We investigated the optical properties of MB in the two perfusate solutions and the formation of photodegradation products under irradiation at 660 nm using UV–visible absorption spectroscopy and liquid chromatography coupled with mass spectrometry (LC-MS). A Staphylococcus aureus strain was used to monitor the antimicrobial response of aPDT at different treatment conditions. The study provided significant insights into the photophysical behavior of MB in the presence of perfusate biomolecules and the consequences of their presence regarding the limited antimicrobial effect observed. The results suggest that the perfusate biomolecules are responsible for quenching the photodynamic action of MB, possibly due to their interaction with the photosensitizer and/or the produced species, trapping molecules, and thus decreasing their interaction with bacterial cells.
Phototherapy, defined as the use of light at specific wavelengths for therapeutic purposes, includes ultraviolet (UV) therapy, photobiomodulation/low-level laser treatment (PBM/LLLT), and photodynamic therapy (PDT). This review examines the effects of these modalities on different types of stem cells, with a particular focus on their capacity to influence cellular processes. Published studies addressing the biological and therapeutic impact of phototherapy on stem cells were critically analyzed to identify targeted mechanisms and their translational potential. Evidence indicates that UV therapy, PBM/LLLT, and PDT uniquely modulate cellular processes and signaling cascades in stem cells, enhancing their proliferation and differentiation into multiple lineages. Phototherapy represents a non-invasive and promising strategy to augment stem cell function. By improving proliferation and differentiation without compromising core properties, these modalities hold significant potential for applications in tissue engineering, regenerative medicine, and cellular therapies.
The decline in the discovery of new antibiotics and the rapid spread of multidrug-resistant microorganisms highlight the need for strategies to intensify microbial production of antimicrobial compounds. Photobiomodulation has emerged as a physical, non-chemical approach capable of modulating cellular metabolism, however, its application to prokaryotic secondary metabolism remains poorly explored. This study evaluated whether red-light LED photobiomodulation can modulate growth-independent antimicrobial activity in Paenibacillus polymyxa RNC-D and identified fluence-dependent metabolic responses. Bacterial growth kinetics were established to define the stationary phase, followed by a photobiomodulation protocol applied under controlled nutritional stress. Cell suspensions were exposed to red LED light (660 ± 2 nm, 35 mW cm⁻²) at fluences of 7, 9, 11, 13, and 15 J cm⁻², delivered at 12 h intervals during nutrient deprivation. Cultures were then transferred to a nutrient-rich medium (Yeast Extract Peptone Medium, YPM) for fermentation. Antimicrobial activity of crude fermented extracts was evaluated against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Candida albicans ATCC 10231. Antimicrobial potency was evaluated using a biomass-normalized potency index (MIC⁻¹/log biomass). Photobiomodulation at 11 J cm⁻² increased this normalized potency index against C. albicans by 262%, while 13 J cm⁻² optimized normalized potency against S. aureus and E. coli by 494% and 247%, respectively, compared to non-irradiated stressed controls. Intermediate fluences yielded higher normalized potency despite reduced biomass, which is consistent with a potential metabolic trade-off favoring secondary metabolism over cell division. These results suggest that red-light photobiomodulation acts as a physical elicitor capable of selectively modulating the antimicrobial potency of P. polymyxa RNC-D fermented extracts.
The decline in the discovery of new antibiotics and the rapid spread of multidrug-resistant microorganisms highlight the need for strategies to intensify microbial production of antimicrobial compounds. Photobiomodulation has emerged as a physical, non-chemical approach capable of modulating cellular metabolism, however, its application to prokaryotic secondary metabolism remains poorly explored. This study evaluated whether red-light LED photobiomodulation can modulate growth-independent antimicrobial activity in Paenibacillus polymyxa RNC-D and identified fluence-dependent metabolic responses. Bacterial growth kinetics were established to define the stationary phase, followed by a photobiomodulation protocol applied under controlled nutritional stress. Cell suspensions were exposed to red LED light (660 ± 2 nm, 35 mW cm⁻²) at fluences of 7, 9, 11, 13, and 15 J cm⁻², delivered at 12 h intervals during nutrient deprivation. Cultures were then transferred to a nutrient-rich medium (Yeast Extract Peptone Medium, YPM) for fermentation. Antimicrobial activity of crude fermented extracts was evaluated against Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Candida albicans ATCC 10231. Antimicrobial potency was evaluated using a biomass-normalized potency index (MIC⁻¹/log biomass). Photobiomodulation at 11 J cm⁻² increased this normalized potency index against C. albicans by 262%, while 13 J cm⁻² optimized normalized potency against S. aureus and E. coli by 494% and 247%, respectively, compared to non-irradiated stressed controls. Intermediate fluences yielded higher normalized potency despite reduced biomass, which is consistent with a potential metabolic trade-off favoring secondary metabolism over cell division. These results suggest that red-light photobiomodulation acts as a physical elicitor capable of selectively modulating the antimicrobial potency of P. polymyxa RNC-D fermented extracts.
Potassium Pheophorbide (KPheo), a chlorophyll derivative from Parachlorella kessleri (P. kessleri) microalga has been evaluated as a photosensitizer (PS) in antimicrobial photodynamic therapy (aPDT). KPheo was semi-synthesized then structurally and photophysicochemically characterized, confirming its successful saponification, molecular integrity, good solubility and stability in aqueous media, attributed to its potassium salt form. This microalgae-derived PS demonstrated notable photostability, with a degradation rate of only 15.68% after 110 s of irradiation. Its strong photodynamic activity was demonstrated by the favorable singlet oxygen (1O2) generation with a 58.96% DPBF absorption decrease after 110 s of irradiation. In vitro antimicrobial assays revealed that KPheo effectively inactivated both Gram-positive (Staphylococcus aureus and Enterococcus faecalis) and Gram-negative bacteria (Escherichia coli, multidrug-resistant (MDR) E. coli, Acinetobacter baumannii and Pseudomonas aeruginosa) under irradiation, with negligible dark toxicity across all tested concentrations (5–1000 µg/mL). E. faecalis emerged as the most sensitive species. While inhibition of bacterial growth at 12 and 30 J/cm2 was restricted to the Gram-positive bacteria, raising the irradiation dose to 60 J/cm2 not only displayed pronounced inhibition zones across all KPheo concentrations for Gram-positive strains, but also included Gram-negative bacteria, with moderate responses at the highest KPheo concentration (1000 µg/mL). Photoactivated KPheo produced significantly greater inhibition zones against all bacterial strains compared to the untreated control (p < 0.05). In silico analysis showed good binding affinities between KPheo and bacterial target proteins, along with favorable pharmacokinetics and safety properties. In summary, KPheo emerges as a promising candidate for further development as an effective PS in aPDT.